Pathogenesis and inflammaging in MDS [MDS Professional Report]
Feb 1, 2025 - 28:47
Radio and PodcastLive Radio & Podcasts![Will Venetoclax Become The New Standard? [MDS Professional Report] artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/7b8bc7d62bbbfefa1a0c2f97a3d163fe.jpg)
Health
Will Venetoclax Become The New Standard? [MDS Professional Report]
We will discuss the addition of venetoclax to hypomethylating agents in the treatment of advanced myeloid neoplasms, especially higher-risk myelodysplastic syndromes.We will then report a study testing the efficacy and s...
About This Episode
Will Venetoclax Become The New Standard? [MDS Professional Report] is an episode from MDS Professional Report by PI Media. We will discuss the addition of venetoclax to hypomethylating agents in the treatment of advanced myeloid neoplasms,...
Podcast
This episode belongs to MDS Professional Report.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jun 2, 2021, 34:49 long, audio available.
Related Episodes
Continue listening to more episodes from MDS Professional Report.
Treatment of lower-risk MDS [MDS Professional Report]
Dec 15, 2024 - 28:57
Treatment for Higher-risk MDS [MDS Professional Report]
Dec 1, 2024 - 28:49
Update on Higher-Risk MDS - Lessons from 2023 ASH [MDS Professional Report]
May 27, 2024 - 21:49
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Mar 27, 2024 - 27:58
Transfusions and quality of life [MDS Professional Report]
May 1, 2023 - 21:49
Bone marrow failure disorders in childhood [MDS Professional Report]
Dec 5, 2022 - 22:31
The role of genetics in MDS management [MDS Professional Report]
Sep 28, 2022 - 22:02